Samalin Investment Counsel, LLC Novavax Inc Transaction History

Samalin Investment Counsel, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $4,535 - $9,411	-125 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $6,973 - $14,290	100 Added 400.0%	125 $9.21 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $3,025 - $6,441	25 New	25 $5,000
Q1 2021 May 11, 2021	SELL	$112.98 - $319.93 $2,824 - $7,998	-25 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$79.44 - $178.51 $1,986 - $4,462	25 New	25 $2,000
Q1 2020 May 04, 2020	SELL	$3.93 - $16.0 $98 - $400	-25 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$3.69 - $5.22 $92 - $130	25 New	25 $0

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.